TY - JOUR
T1 - The glutathione-related detoxification system is increased in human breast cancer in correlation with clinical and histopathological features
AU - Perquin, Magali
AU - Oster, Thierry
AU - Maul, Armand
AU - Froment, Nicolas
AU - Untereiner, Michel
AU - Bagrel, Denyse
N1 - Funding Information:
Acknowledgements This work was supported by the Comité de Moselle of the Ligue contre le Cancer that provided essential financial support and a fellowship to MP. We are grateful to the Région de Lorraine (Poà le Technologique Régional de Génie Bio-logique et Médical) for its financial contribution. We also thank the vital contribution of the staff at the Service d'Anatomie Patho-logique at Bon-Secours hospital (Metz, France) for its excellent collaboration in collecting tissue samples.
PY - 2001
Y1 - 2001
N2 - Purpose: The glutathione detoxification pathway includes glutathione S-transferase (GST) and peroxidase (GPX) isoenzymes as well as glutathione reductase (GSSR). Though well established from cultured cancer cell lines, its involvement in resistance is still unclear in the tumours. This study aimed to describe the parameters that influence the glutathione contents and associated activities in breast cancer. Methods: The components of the glutathione pathway were measured in the tumours from 41 women with primary breast cancer in comparison with those in the matched tumour-free samples. Appropriate statistical studies (regression analysis, Wilcoxon signed rank test) explored the influence of clinical and prognostic factors. Results: Reduced and total glutathione contents were largely increased (P < 0.0001) and all related activities were significantly enhanced in the tumours. Interindividual variations were described, probably due to various parameters (age, menopause, axillary lymph node status, S and G2 + M cell fractions, ER, cathepsin-D and c-ErbB-2 expressions) that influence particular components of the glutathione pathway, especially the glutathione levels. Conclusions: The breast tumours improved their redox status and detoxification capacities depending on various parameters of significance for cell proliferation and aggressiveness, which supports the involvement of the glutathione pathway in malignant cell resistance to oxidative stress and apoptosis.
AB - Purpose: The glutathione detoxification pathway includes glutathione S-transferase (GST) and peroxidase (GPX) isoenzymes as well as glutathione reductase (GSSR). Though well established from cultured cancer cell lines, its involvement in resistance is still unclear in the tumours. This study aimed to describe the parameters that influence the glutathione contents and associated activities in breast cancer. Methods: The components of the glutathione pathway were measured in the tumours from 41 women with primary breast cancer in comparison with those in the matched tumour-free samples. Appropriate statistical studies (regression analysis, Wilcoxon signed rank test) explored the influence of clinical and prognostic factors. Results: Reduced and total glutathione contents were largely increased (P < 0.0001) and all related activities were significantly enhanced in the tumours. Interindividual variations were described, probably due to various parameters (age, menopause, axillary lymph node status, S and G2 + M cell fractions, ER, cathepsin-D and c-ErbB-2 expressions) that influence particular components of the glutathione pathway, especially the glutathione levels. Conclusions: The breast tumours improved their redox status and detoxification capacities depending on various parameters of significance for cell proliferation and aggressiveness, which supports the involvement of the glutathione pathway in malignant cell resistance to oxidative stress and apoptosis.
KW - Breast cancer
KW - Glutathione pathway
KW - Proliferation markers
KW - Resistance
UR - http://www.scopus.com/inward/record.url?scp=0035001370&partnerID=8YFLogxK
UR - https://pubmed.ncbi.nlm.nih.gov/11414197
U2 - 10.1007/s004320000228
DO - 10.1007/s004320000228
M3 - Article
C2 - 11414197
AN - SCOPUS:0035001370
SN - 0171-5216
VL - 127
SP - 368
EP - 374
JO - Journal of Cancer Research and Clinical Oncology
JF - Journal of Cancer Research and Clinical Oncology
IS - 6
ER -